{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:53:50Z","timestamp":1784332430743,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,4,16]],"date-time":"2010-04-16T00:00:00Z","timestamp":1271376000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s00347-009-2100-4","type":"journal-article","created":{"date-parts":[[2010,4,14]],"date-time":"2010-04-14T10:21:55Z","timestamp":1271240515000},"page":"517-524","source":"Crossref","is-referenced-by-count":15,"title":["Pterygium"],"prefix":"10.1007","volume":"107","author":[{"given":"L.M.","family":"Heindl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cursiefen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,16]]},"reference":[{"key":"2100_CR1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/ICU.0b013e3281a7ecbb","volume":"18","author":"Ang","year":"2007","unstructured":"Ang LP, Chua JL, Tan DT (2007) Current concepts and techniques in pterygium treatment. Curr Opin Ophthalmol 18:308\u2013313","journal-title":"Curr Opin Ophthalmol"},{"key":"2100_CR2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/02713680701799101","volume":"33","author":"Bahar","year":"2008","unstructured":"Bahar I, Kaiserman I, McAllum P et al (2008) Subconjunctival bevacizumab injection for corneal neovascularisation in recurrent pterygium. Curr Eye Res 33:23\u201328","journal-title":"Curr Eye Res"},{"key":"2100_CR3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00417-007-0684-4","volume":"246","author":"Bock","year":"2008","unstructured":"Bock F, K\u00f6nig Y, Kruse F et al (2008) Bevacizumab (Avastin) eye drops inhibit corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 246:281\u2013284","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2100_CR4","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1167\/iovs.07-1129","volume":"50","author":"Bock","year":"2009","unstructured":"Bock F, Onderka J, Rummelt C et al (2009) Safety profile of topical VEGF neutralization at the cornea. Invest Ophthalmol Vis Sci 50:2095\u20132102","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2100_CR5","unstructured":"Bradley JC, Yang W, Bradley RH et al (2009) The science of pterygium. Br J Ophthalmol, Epub ahead of print"},{"key":"2100_CR6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S1542-0124(12)70103-9","volume":"6","author":"Chui","year":"2008","unstructured":"Chui J, Di Girolamo N, Wakefield D, Coroneo MT (2008) The pathogenesis of pterygium: current concepts and their therapeutic implications. Ocul Surf 6:24\u201343","journal-title":"Ocul Surf"},{"key":"2100_CR7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00347-009-1933-1","volume":"106","author":"Cursiefen","year":"2009","unstructured":"Cursiefen C (2009) Bevacizumab goes anterior: antiangiogenic therapy at cornea and conjunctiva. Ophthalmologe 106:397\u2013398","journal-title":"Ophthalmologe"},{"key":"2100_CR8","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.ophtha.2009.04.016","volume":"116","author":"Cursiefen","year":"2009","unstructured":"Cursiefen C, Bock F, Horn FK et al (2009) GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial. Ophthalmology 116:1630\u20131637","journal-title":"Ophthalmology"},{"key":"2100_CR9","unstructured":"Cursiefen C, Kruse FE, Naumann GOH (2008) Conjunctiva and limbus corneae. In: Naumann GOH, Holbach L, Kruse FE (eds) Applied pathology for ophthalmic microsurgeons. Springer, Berlin Heidelberg, pp 67\u201375"},{"key":"2100_CR10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.preteyeres.2004.02.002","volume":"23","author":"Di","year":"2004","unstructured":"Di Girolamo N, Chui J, Coroneo MT et al (2004) Pathogenesis of pterygia: role of cytokines, growth factors and matrix metalloproteinases. Prog Retin Eye Res 23:195\u2013228","journal-title":"Prog Retin Eye Res"},{"key":"2100_CR11","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ophtha.2005.01.023","volume":"112","author":"Gebhardt","year":"2005","unstructured":"Gebhardt M, Mentlein R, Schaudig U et al (2005) Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia. Ophthalmology 112:1023\u20131030","journal-title":"Ophthalmology"},{"key":"2100_CR12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0039-6257(02)00463-0","volume":"48","author":"Hirst","year":"2003","unstructured":"Hirst LW (2003) The treatment of pterygium. Surv Ophthalmol 48:145\u2013180","journal-title":"Surv Ophthalmol"},{"key":"2100_CR13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/archophthalmol.2008.531","volume":"127","author":"Hirst","year":"2009","unstructured":"Hirst LW, Axelsen RA, Schwab I (2009) Pterygium and associated ocular surface squamous neoplasia. Arch Ophthalmol 127:31\u201332","journal-title":"Arch Ophthalmol"},{"key":"2100_CR14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3928\/15428877-20090430-03","volume":"40","author":"Ib\u00e1\u00f1ez","year":"2009","unstructured":"Ib\u00e1\u00f1ez M, Eugarrios MF, Calder\u00f3n DI (2009) Topical cyclosporin A and mitomycin C injection as adjunctive therapy for prevention of primary pterygium recurrence. Ophthalmic Surg Lasers Imaging 40:239\u2013244","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"2100_CR15","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.ophtha.2008.02.013","volume":"115","author":"Kim","year":"2008","unstructured":"Kim SW, Ha BJ, Kim EK et al (2008) The effect of topical bevacizumab on corneal neovascularisation. Ophthalmology 115:e33\u2013e38","journal-title":"Ophthalmology"},{"key":"2100_CR16","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1167\/iovs.08-2805","volume":"50","author":"Kim","year":"2009","unstructured":"Kim TI, Chung JL, Hong JP et al (2009) Bevacizumab application delays epithelial healing in rabbit cornea. Invest Ophthalmol Vis Sci 50:4653\u20134659","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2100_CR17","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s003470170055","volume":"98","author":"Kruse","year":"2001","unstructured":"Kruse FE, Meller D (2001) Amniotic membrane transplantation for reconstruction of the ocular surface. Ophthalmologe 98:801\u2013810","journal-title":"Ophthalmologe"},{"key":"2100_CR18","unstructured":"Kruse FE, V\u00f6lcker HE, Naumann GOH (1997) Konjunktiva. In: Naumann GOH (Hrsg) Pathologie des Auges. Springer, Berlin Heidelberg, S 379\u2013506"},{"key":"2100_CR19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00347-009-1936-y","volume":"105","author":"Leippi","year":"2009","unstructured":"Leippi S, Grehn F, Geerling G (2009) Antiangiogenic therapy for pterygium recurrence. Ophthalmologe 105:413\u2013419","journal-title":"Ophthalmologe"},{"key":"2100_CR20","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0002-9394(98)00140-8","volume":"126","author":"Lim","year":"1998","unstructured":"Lim R, Mitchell P, Cumming RG (1998) Cataract associations with pinguecula and pterygium: the Blue Mountains Eye Study. Am J Ophthalmol 126:717\u2013719","journal-title":"Am J Ophthalmol"},{"key":"2100_CR21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/bjo.68.5.343","volume":"68","author":"Moran","year":"1984","unstructured":"Moran DJ, Hollows FC (1984) Pterygium and ultraviolet radiation: a positive correlation. Br J Ophthalmol 68:343\u2013346","journal-title":"Br J Ophthalmol"},{"key":"2100_CR22","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/ICO.0b013e318162af90","volume":"27","author":"Paris","year":"2008","unstructured":"Paris Fdos S, Farias CC de, Melo GB et al (2008) Postoperative subconjunctival corticosteroid injection to prevent pterygium recurrence. Cornea 27:406\u2013410","journal-title":"Cornea"},{"key":"2100_CR23","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ajo.2004.08.070","volume":"139","author":"Pham","year":"2005","unstructured":"Pham TQ, Wang JJ, Rochtchina E, Mitchell P (2005) Pterygium\/pinguecula and the five-year incidence of age-related maculopathy. Am J Ophthalmol 139:536\u2013537","journal-title":"Am J Ophthalmol"},{"key":"2100_CR24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00347-009-1934-0","volume":"106","author":"Regenfuss","year":"2009","unstructured":"Regenfuss B, Bock F, Bachmann B et al (2009) Topical inhibition of angiogenesis at the cornea. Safety and efficacy. Ophthalmologe 106:399\u2013406","journal-title":"Ophthalmologe"},{"key":"2100_CR25","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0161-6420(92)31749-X","volume":"99","author":"Rubinfeld","year":"1992","unstructured":"Rubinfeld RS, Pfister RR, Stein RM et al (1992) Serious complications of topical mitomycin-C after pterygium surgery. Ophthamology 99:1647\u20131654","journal-title":"Ophthamology"},{"key":"2100_CR26","unstructured":"Sekundo W, Droutsas K, Cursiefen C (o J) Operative Techniken bei chirurgischer Behandlung prim\u00e4rer und rezidivierender Pterygien. Ophthalmologe (dieses Heft)"},{"key":"2100_CR27","first-page":"688","volume":"90","author":"Soriano","year":"1993","unstructured":"Soriano JM, Janknecht P, Witschel H (1993) Effect of pterygium operation on preoperative astigmatism. Prospective study. Ophthalmologe 90:688\u2013690","journal-title":"Ophthalmologe"},{"key":"2100_CR28","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00055735-200208000-00003","volume":"13","author":"Ti","year":"2002","unstructured":"Ti SE, Tseng SC (2002) Management of primary and recurrent pterygium using amniotic membrane transplantation. Curr Opin Ophthalmol 13:204\u2013212","journal-title":"Curr Opin Ophthalmol"},{"key":"2100_CR29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/ICO.0b013e3181644581","volume":"27","author":"Tsai","year":"2008","unstructured":"Tsai YY, Chiang CC, Bau DT et al (2008) Vascular endothelial growth factor gene 460 polymorphism is associated with pterygium formation in female patients. Cornea 27:476\u2013479","journal-title":"Cornea"},{"key":"2100_CR30","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s00066-009-2000-1","volume":"185","author":"Vastardis","year":"2009","unstructured":"Vastardis I, Pajic B, Greiner RH et al (2009) Prospective study of exclusive strontium-\/yttrium-90 beta-irradiation of primary and recurrent pterygia with no prior surgical excision. Clinical outcome of long-term follow-up. Strahlenther Onkol 185:808\u2013814","journal-title":"Strahlenther Onkol"},{"key":"2100_CR31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/ICO.0b013e3181822615","volume":"28","author":"Wu","year":"2009","unstructured":"Wu PC, Kuo HK, Tai MH, Shin SJ (2009) Topical bevacizumab eyedrops for limbal-conjunctival neovascularization in impending recurrent pterygium. Cornea 28:103\u2013104","journal-title":"Cornea"},{"key":"2100_CR32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/ICO.0b013e318187544d","volume":"28","author":"Young","year":"2009","unstructured":"Young AL, Tam PM, Leung GY et al (2009) Prospective study on the safety and efficacy of combined conjunctival rotational autograft with intraoperative 0,02% mitomycin C in primary pterygium excision. Cornea 28:166\u2013169","journal-title":"Cornea"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-009-2100-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-009-2100-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-009-2100-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:50:59Z","timestamp":1559051459000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-009-2100-4"}},"subtitle":["\u00c4tiologie, Klinik und neue adjuvante Therapien","Etiology, clinical aspects and novel adjuvant therapies"],"short-title":[],"issued":{"date-parts":[[2010,4,16]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["2100"],"URL":"https:\/\/doi.org\/10.1007\/s00347-009-2100-4","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,16]]}}}